Onset Dermatologics Launches New Strength of Minocin

Onset Dermatologics launced a 75mg strength of Minocin (minocycline hydrochloride) Pellet-Filled Capsules, a tetracycline class antibiotic medicine used to treat infections caused by bacteria. Minocin may be used along with other agents in the treatment of severe acne.

With this launch, Minocin is now available in three strengths—50mg, 75mg, and 100mg.

“With three strengths of Minocin, dermatology practitioners are able to tailor therapy with the original minocycline to meet the needs of many patients,” said Robert Moccia, President, Onset Dermatologics and CEO, Precision Dermatology.

“Minocycline is a second generation tetracycline commonly used in acne because of its efficacy and ease in dosing. Minocycline is effective in the treatment of acne because it has high tissue penetration, related to the molecule's affinity for lipids such as sebum. Minocycline is readily absorbed whether taken with or without food,” said Dr. Neal Bhatia, Associate Professor of Dermatology at Harbor UCLA. “The option of three different strengths of Minocin enables dermatologists to individualize treatment regimens, balancing efficacy and the potential for adverse events.”

For full prescribing information, visit www.minocin.com.